Incyte INCY Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 92.5%-0.3pp | 92.8%-0.2pp | 92.9%+0.1pp | 92.9%+0.2pp | 92.7%0.0pp | |
| Operating margin | 30%+0.6pp | 29.5%-1.3pp | 30.8%+5.0pp | 25.8%+21.8pp | 4%+2.5pp | |
| Net margin | 26.7%+1.7pp | 25%+0.3pp | 24.7%+5.7pp | 19%+18.5pp | 0.5%-0.3pp | |
| EBITDA margin | 31.8%+0.5pp | 31.3%-1.4pp | 32.7%+4.9pp | 27.8%+21.8pp | 6%+2.4pp | |
| Free cash flow margin | 28.2%+0.8pp | 27.4%+1.5pp | 25.9%+4.2pp | 21.7%+13.2pp | 8.6%+0.7pp | |
| Returns | ||||||
| Return on equity | 30.8%+1.0pp | 29.9%-0.5pp | 30.4%+6.1pp | 24.3%+23.8pp | 0.5%-0.3pp | |
| Return on assets | 21.9%+1.1pp | 20.7%-0.2pp | 21%+4.3pp | 16.6%+16.3pp | 0.3%-0.2pp | |
| Return on invested capital | 65.6%+6.3pp | 59.3%+5.7pp | 53.6%+15.6pp | 37.9%+33.4pp | 4.5%+2.9pp | |
| Efficiency | ||||||
| Asset turnover | 0.8×0.0× | 0.8×0.0× | 0.8×0.0× | 0.9×+0.2× | 0.7×0.0× | |
| Inventory turnover | 1.2×+0.1× | 1.1×+0.1× | 1×0.0× | 1×0.0× | 1×-0.1× | |
| Liquidity | ||||||
| Current ratio | 3.7×+0.4× | 3.3×+0.1× | 3.2×+0.3× | 2.8×+0.8× | 2×+0.1× | |
| Quick ratio | 3.5×+0.4× | 3.1×+0.2× | 2.9×+0.4× | 2.6×+0.7× | 1.8×+0.1× | |
| Cash ratio | 2.3×+0.3× | 2×+0.2× | 1.8×+0.3× | 1.5×+0.4× | 1.1×+0.1× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Net debt / EBITDA | -2×-0.1× | -1.9×-0.4× | -1.5×0.0× | -1.5×+5.7× | -7.2×+3.6× | |
| Interest coverage | 689.3×+65.4× | 623.9×-29.7× | 653.6×+170× | 483.5×+414× | 69.6×+42.7× | |
| Per Share | ||||||
| Book value per share | $27.19+5.6% | $25.75+11.5% | $23.09+10.0% | $20.99+13.4% | $18.50+13.0% | |
| Valuation | ||||||
| Market capitalization | $18.73B-3.4% | $19.39B+17.1% | $16.56B+24.0% | $13.36B+14.0% | $11.72B-11.9% | |
| Enterprise value | $15.31B-6.4% | $16.35B+15.6% | $14.15B+23.6% | $11.44B+16.6% | $9.82B-16.0% | |
| Price / earnings | 13.1×-2.0× | 15.1×+1.1× | 13.9×-1.4× | 15.3×-536× | 550.9×+143× | |
| Price / sales | 3.5×-0.3× | 3.8×+0.3× | 3.4×+0.5× | 2.9×+0.3× | 2.7×-0.5× | |
| Price / book | 3.3×-0.4× | 3.8×+0.2× | 3.6×+0.4× | 3.2×0.0× | 3.2×-0.7× | |
| EV / EBITDA | 9×-1.2× | 10.2×+1.2× | 9×0.0× | 9×-28.2× | 37.1×-40.4× | |
| EV / sales | 2.9×-0.3× | 3.2×+0.2× | 2.9×+0.4× | 2.5×+0.3× | 2.2×-0.5× | |
| Free cash flow yield | 8.1%+0.8pp | 7.3%-0.3pp | 7.5%+0.1pp | 7.5%+4.2pp | 3.2%+0.7pp | |
| Earnings yield | 7.6%+1.0pp | 6.6%-0.5pp | 7.2%+0.7pp | 6.5%+6.3pp | 0.2%-0.1pp | |
| PEG ratio | 0×0.0× | 0×0.0× | 0×0.0× | 0×— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Incyte's profit margins?
- Incyte (INCY) runs a 92.5% gross margin and a 30.0% operating margin, with a 26.7% net margin.
- Where do Incyte's ratios come from?
- Every ratio is computed from Incyte's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
